Viyash Scientific Ltd.
•₹ 275.953.8%
2026-08-21
PROS
- Promoters have been increasing their shareholding - up 8.5pp over 2 years
- Latest quarter profit grew 351.3% YoY, showing strong momentum
- Operating margins have improved to 19.1% from 1.3%
- Company has delivered good sales growth of 20.2% CAGR over last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 3.31x)
CONS
- Company has a low return on equity of 1.8% over last 3 years
- Company has a low return on capital employed of 5.8%
- Receivables are growing faster than sales - a possible quality concern
- Equity base is being diluted - shares outstanding up 75.1%
- Working capital days have increased from 93 to 140 days
- Recurring exceptional / one-off items are inflating headline profit
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | VIYASH | 271.95 | 69.90 | 11963.29 | 0.00 | 792.90 | 4412.81 | 9463.60 | 2043.90 | 13.10 | 18.85 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 333 | 346 | 329 | 361 | 390 | 369 | 774 | 772 | 441 | 424 | 858 | 920 | 9,464 | |
| 341 | 331 | 307 | 329 | 348 | 330 | 674 | 659 | 389 | 368 | 683 | 736 | 8,423 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 1 | 2 | 5 | 4 | 3 | 5 | 7 | 10 | 4 | 2 | 14 | 16 | 83 |
| Interest | 10 | 13 | 13 | 12 | 16 | 14 | 21 | 21 | 14 | 14 | 17 | 15 | 125 |
| Depreciation | 14 | 15 | 15 | 16 | 16 | 17 | 58 | 65 | 15 | 15 | 59 | 60 | 618 |
| -56 | -3 | 1 | 3 | 12 | 8 | 24 | -37 | 26 | 27 | 73 | 125 | 1,124 | |
| Tax % | 37.72% | -122.65% | -616.78% | 51.89% | 24.50% | 19.75% | -71.32% | 12.22% | 31.15% | 27.84% | 33.60% | 47.00% | 29.46% |
| Net Profit | 0 | 0 | 0 | 0 | 9 | 6 | 65 | 104 | 18 | 20 | 49 | 66 | 793 |
| -1 | -0 | 0 | -0 | 0 | 0 | 1 | -1 | 1 | 1 | 1 | 1 | 2 | |
| Equity Capital | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 87 | 87 | 874 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 87 | 87 | 874 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 333
- 341
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 10
- Depreciation
- 14
- -56
- Tax %
- 37.72%
- Net Profit
- 0
- -1
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 346
- 331
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 13
- Depreciation
- 15
- -3
- Tax %
- -122.65%
- Net Profit
- 0
- -0
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 329
- 307
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 13
- Depreciation
- 15
- 1
- Tax %
- -616.78%
- Net Profit
- 0
- 0
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 361
- 329
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 12
- Depreciation
- 16
- 3
- Tax %
- 51.89%
- Net Profit
- 0
- -0
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 390
- 348
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 16
- Depreciation
- 16
- 12
- Tax %
- 24.50%
- Net Profit
- 9
- 0
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 369
- 330
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 14
- Depreciation
- 17
- 8
- Tax %
- 19.75%
- Net Profit
- 6
- 0
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 774
- 674
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 21
- Depreciation
- 58
- 24
- Tax %
- -71.32%
- Net Profit
- 65
- 1
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 772
- 659
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 21
- Depreciation
- 65
- -37
- Tax %
- 12.22%
- Net Profit
- 104
- -1
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 441
- 389
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 14
- Depreciation
- 15
- 26
- Tax %
- 31.15%
- Net Profit
- 18
- 1
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 424
- 368
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 14
- Depreciation
- 15
- 27
- Tax %
- 27.84%
- Net Profit
- 20
- 1
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 50
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 858
- 683
- Operating Profit
- —
- OPM %
- —
- Other Income
- 14
- Interest
- 17
- Depreciation
- 59
- 73
- Tax %
- 33.60%
- Net Profit
- 49
- 1
- Equity Capital
- 87
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 87
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 920
- 736
- Operating Profit
- —
- OPM %
- —
- Other Income
- 16
- Interest
- 15
- Depreciation
- 60
- 125
- Tax %
- 47.00%
- Net Profit
- 66
- 1
- Equity Capital
- 87
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 87
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 9,464
- 8,423
- Operating Profit
- —
- OPM %
- —
- Other Income
- 83
- Interest
- 125
- Depreciation
- 618
- 1,124
- Tax %
- 29.46%
- Net Profit
- 793
- 2
- Equity Capital
- 874
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 874
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 684 | 848 | 1,039 | 1,179 | 1,362 | 1,413 | 1,421 | 1,370 | 3,007 | 3,420 | 11,666 | |
| 641 | 765 | 914 | 1,009 | 1,152 | 1,303 | 1,409 | 1,308 | 2,623 | 2,768 | 10,209 | |
| Operating Profit | 54 | 100 | 134 | 180 | 220 | 120 | 18 | 72 | 420 | 696 | — |
| OPM % | 8 | 12 | 13 | 15 | 16 | 9 | 1 | 5 | 14 | 20 | — |
| Other Income | 11 | 17 | 9 | 10 | 10 | 11 | 6 | 11 | 36 | 44 | 115 |
| Interest | 28 | 33 | 33 | 36 | 24 | 16 | 36 | 48 | 86 | 69 | 170 |
| Depreciation | 40 | 41 | 42 | 51 | 51 | 52 | 56 | 62 | 239 | 234 | 752 |
| -14 | 24 | 59 | 94 | 137 | 53 | -138 | -55 | 13 | 349 | 1,350 | |
| Tax % | 4 | 57 | 3 | 13 | 24 | 15 | 11 | 46 | -20 | 36 | 31 |
| Net Profit | -14 | 10 | 57 | 82 | 104 | 45 | -122 | -30 | 16 | 225 | 927 |
| EPS | -1 | 17 | 2 | 3 | 4 | 2 | -5 | -1 | 1 | 4 | — |
| Dividend Payout % | 0 | 1 | 10 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 3 | -9 | -8 | -12 | -9 | -4 | 1 | -6 | 7 | -47 | 110 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -1 | 17 | 2 | 3 | 4 | 2 | -5 | -1 | 1 | 4 | — |
| Minority Interest | 3 | -9 | -8 | -12 | -9 | -4 | 1 | -6 | 7 | -47 | 110 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -1 | 17 | 2 | 3 | 4 | 2 | -5 | -1 | 1 | 4 | — |
Mar 2017
- 684
- 641
- Operating Profit
- 54
- OPM %
- 8
- Other Income
- 11
- Interest
- 28
- Depreciation
- 40
- -14
- Tax %
- 4
- Net Profit
- -14
- EPS
- -1
- Dividend Payout %
- 0
- Minority Interest
- 3
- Share of Associates
- 0
- Adjusted EPS
- -1
- Minority Interest
- 3
- Share of Associates
- 0
- Adjusted EPS
- -1
Mar 2018
- 848
- 765
- Operating Profit
- 100
- OPM %
- 12
- Other Income
- 17
- Interest
- 33
- Depreciation
- 41
- 24
- Tax %
- 57
- Net Profit
- 10
- EPS
- 17
- Dividend Payout %
- 1
- Minority Interest
- -9
- Share of Associates
- 0
- Adjusted EPS
- 17
- Minority Interest
- -9
- Share of Associates
- 0
- Adjusted EPS
- 17
Mar 2019
- 1,039
- 914
- Operating Profit
- 134
- OPM %
- 13
- Other Income
- 9
- Interest
- 33
- Depreciation
- 42
- 59
- Tax %
- 3
- Net Profit
- 57
- EPS
- 2
- Dividend Payout %
- 10
- Minority Interest
- -8
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- -8
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2020
- 1,179
- 1,009
- Operating Profit
- 180
- OPM %
- 15
- Other Income
- 10
- Interest
- 36
- Depreciation
- 51
- 94
- Tax %
- 13
- Net Profit
- 82
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- -12
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- -12
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2021
- 1,362
- 1,152
- Operating Profit
- 220
- OPM %
- 16
- Other Income
- 10
- Interest
- 24
- Depreciation
- 51
- 137
- Tax %
- 24
- Net Profit
- 104
- EPS
- 4
- Dividend Payout %
- 13
- Minority Interest
- -9
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- -9
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2022
- 1,413
- 1,303
- Operating Profit
- 120
- OPM %
- 9
- Other Income
- 11
- Interest
- 16
- Depreciation
- 52
- 53
- Tax %
- 15
- Net Profit
- 45
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- -4
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- -4
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2023
- 1,421
- 1,409
- Operating Profit
- 18
- OPM %
- 1
- Other Income
- 6
- Interest
- 36
- Depreciation
- 56
- -138
- Tax %
- 11
- Net Profit
- -122
- EPS
- -5
- Dividend Payout %
- 0
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- -5
- Minority Interest
- 1
- Share of Associates
- 0
- Adjusted EPS
- -5
Mar 2024
- 1,370
- 1,308
- Operating Profit
- 72
- OPM %
- 5
- Other Income
- 11
- Interest
- 48
- Depreciation
- 62
- -55
- Tax %
- 46
- Net Profit
- -30
- EPS
- -1
- Dividend Payout %
- 0
- Minority Interest
- -6
- Share of Associates
- 0
- Adjusted EPS
- -1
- Minority Interest
- -6
- Share of Associates
- 0
- Adjusted EPS
- -1
Mar 2025
- 3,007
- 2,623
- Operating Profit
- 420
- OPM %
- 14
- Other Income
- 36
- Interest
- 86
- Depreciation
- 239
- 13
- Tax %
- -20
- Net Profit
- 16
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 7
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 7
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2026
- 3,420
- 2,768
- Operating Profit
- 696
- OPM %
- 20
- Other Income
- 44
- Interest
- 69
- Depreciation
- 234
- 349
- Tax %
- 36
- Net Profit
- 225
- EPS
- 4
- Dividend Payout %
- 0
- Minority Interest
- -47
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- -47
- Share of Associates
- 0
- Adjusted EPS
- 4
TTM
- 11,666
- 10,209
- Operating Profit
- —
- OPM %
- —
- Other Income
- 115
- Interest
- 170
- Depreciation
- 752
- 1,350
- Tax %
- 31
- Net Profit
- 927
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 110
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 110
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 19%
- 5 Years:
- 20%
- 3 Years:
- 34%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 13%
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- 3%
- 5 Years:
- -1%
- 3 Years:
- 2%
- Last Year:
- 9%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 49 | 49 | 49 | 50 | 50 | 50 | 50 | 50 | 50 | 87 |
| 912 | 581 | 638 | 623 | 670 | 595 | 593 | 529 | 2,202 | 2,618 | |
| 246 | 194 | 176 | 193 | 130 | 190 | 182 | 246 | 204 | 122 | |
| Trade Payables | 203 | 160 | 209 | 220 | 227 | 258 | 244 | 251 | 489 | 597 |
| 493 | 359 | 329 | 377 | 367 | 394 | 415 | 455 | 1,075 | 1,121 | |
| Total Liabilities | 1,904 | 1,343 | 1,402 | 1,463 | 1,443 | 1,487 | 1,484 | 1,531 | 4,020 | 4,545 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 684 | 476 | 498 | 577 | 536 | 564 | 605 | 592 | 2,103 | 2,103 | |
| Capital Work in Progress | 2 | 13 | 17 | 11 | 29 | 9 | 51 | 11 | 43 | 69 |
| 428 | 239 | 180 | 171 | 83 | 38 | 0 | 4 | 0 | 0 | |
| 161 | 159 | 200 | 219 | 264 | 348 | 346 | 346 | 682 | 803 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 336 | 806 | 1,045 | |
| Cash & Bank | 47 | 42 | 72 | 76 | 56 | 59 | 42 | 70 | 157 | 270 |
| 582 | 413 | 434 | 409 | 475 | 468 | 439 | 173 | 228 | 255 | |
| Total Assets | 1,904 | 1,343 | 1,402 | 1,463 | 1,443 | 1,487 | 1,484 | 1,531 | 4,020 | 4,545 |
| Total Debt | 416 | 305 | 325 | 343 | 225 | 315 | 398 | 451 | 608 | 436 |
| Net Working Capital | 49 | 107 | 166 | 209 | 254 | 271 | 221 | 184 | 768 | 1,309 |
| Contingent Liabilities | 1 | 0 | 0 | 0 | 2 | 2 | 1 | 4 | 15 | 27 |
| Book Value per Share | 39.44 | 25.85 | 27.86 | 27.10 | 28.98 | 25.97 | 25.76 | 23.22 | 89.96 | 61.92 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Total Debt | 416 | 305 | 325 | 343 | 225 | 315 | 398 | 451 | 608 | 436 |
| Net Working Capital | 49 | 107 | 166 | 209 | 254 | 271 | 221 | 184 | 768 | 1,309 |
| Contingent Liabilities | 1 | 0 | 0 | 0 | 2 | 2 | 1 | 4 | 15 | 27 |
| Book Value per Share | 39.44 | 25.85 | 27.86 | 27.10 | 28.98 | 25.97 | 25.76 | 23.22 | 89.96 | 61.92 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Mar 2017
- Equity Capital
- 49
- 912
- 246
- Trade Payables
- 203
- 493
- Total Liabilities
- 1,904
- 684
- Capital Work in Progress
- 2
- 428
- 161
- 0
- Cash & Bank
- 47
- 582
- Total Assets
- 1,904
- Total Debt
- 416
- Net Working Capital
- 49
- Contingent Liabilities
- 1
- Book Value per Share
- 39.44
- Face Value
- 2.00
- Total Debt
- 416
- Net Working Capital
- 49
- Contingent Liabilities
- 1
- Book Value per Share
- 39.44
- Face Value
- 2.00
Mar 2018
- Equity Capital
- 49
- 581
- 194
- Trade Payables
- 160
- 359
- Total Liabilities
- 1,343
- 476
- Capital Work in Progress
- 13
- 239
- 159
- 0
- Cash & Bank
- 42
- 413
- Total Assets
- 1,343
- Total Debt
- 305
- Net Working Capital
- 107
- Contingent Liabilities
- 0
- Book Value per Share
- 25.85
- Face Value
- 2.00
- Total Debt
- 305
- Net Working Capital
- 107
- Contingent Liabilities
- 0
- Book Value per Share
- 25.85
- Face Value
- 2.00
Mar 2019
- Equity Capital
- 49
- 638
- 176
- Trade Payables
- 209
- 329
- Total Liabilities
- 1,402
- 498
- Capital Work in Progress
- 17
- 180
- 200
- 0
- Cash & Bank
- 72
- 434
- Total Assets
- 1,402
- Total Debt
- 325
- Net Working Capital
- 166
- Contingent Liabilities
- 0
- Book Value per Share
- 27.86
- Face Value
- 2.00
- Total Debt
- 325
- Net Working Capital
- 166
- Contingent Liabilities
- 0
- Book Value per Share
- 27.86
- Face Value
- 2.00
Mar 2020
- Equity Capital
- 50
- 623
- 193
- Trade Payables
- 220
- 377
- Total Liabilities
- 1,463
- 577
- Capital Work in Progress
- 11
- 171
- 219
- 0
- Cash & Bank
- 76
- 409
- Total Assets
- 1,463
- Total Debt
- 343
- Net Working Capital
- 209
- Contingent Liabilities
- 0
- Book Value per Share
- 27.10
- Face Value
- 2.00
- Total Debt
- 343
- Net Working Capital
- 209
- Contingent Liabilities
- 0
- Book Value per Share
- 27.10
- Face Value
- 2.00
Mar 2021
- Equity Capital
- 50
- 670
- 130
- Trade Payables
- 227
- 367
- Total Liabilities
- 1,443
- 536
- Capital Work in Progress
- 29
- 83
- 264
- 0
- Cash & Bank
- 56
- 475
- Total Assets
- 1,443
- Total Debt
- 225
- Net Working Capital
- 254
- Contingent Liabilities
- 2
- Book Value per Share
- 28.98
- Face Value
- 2.00
- Total Debt
- 225
- Net Working Capital
- 254
- Contingent Liabilities
- 2
- Book Value per Share
- 28.98
- Face Value
- 2.00
Mar 2022
- Equity Capital
- 50
- 595
- 190
- Trade Payables
- 258
- 394
- Total Liabilities
- 1,487
- 564
- Capital Work in Progress
- 9
- 38
- 348
- 0
- Cash & Bank
- 59
- 468
- Total Assets
- 1,487
- Total Debt
- 315
- Net Working Capital
- 271
- Contingent Liabilities
- 2
- Book Value per Share
- 25.97
- Face Value
- 2.00
- Total Debt
- 315
- Net Working Capital
- 271
- Contingent Liabilities
- 2
- Book Value per Share
- 25.97
- Face Value
- 2.00
Mar 2023
- Equity Capital
- 50
- 593
- 182
- Trade Payables
- 244
- 415
- Total Liabilities
- 1,484
- 605
- Capital Work in Progress
- 51
- 0
- 346
- 0
- Cash & Bank
- 42
- 439
- Total Assets
- 1,484
- Total Debt
- 398
- Net Working Capital
- 221
- Contingent Liabilities
- 1
- Book Value per Share
- 25.76
- Face Value
- 2.00
- Total Debt
- 398
- Net Working Capital
- 221
- Contingent Liabilities
- 1
- Book Value per Share
- 25.76
- Face Value
- 2.00
Mar 2024
- Equity Capital
- 50
- 529
- 246
- Trade Payables
- 251
- 455
- Total Liabilities
- 1,531
- 592
- Capital Work in Progress
- 11
- 4
- 346
- 336
- Cash & Bank
- 70
- 173
- Total Assets
- 1,531
- Total Debt
- 451
- Net Working Capital
- 184
- Contingent Liabilities
- 4
- Book Value per Share
- 23.22
- Face Value
- 2.00
- Total Debt
- 451
- Net Working Capital
- 184
- Contingent Liabilities
- 4
- Book Value per Share
- 23.22
- Face Value
- 2.00
Mar 2025
- Equity Capital
- 50
- 2,202
- 204
- Trade Payables
- 489
- 1,075
- Total Liabilities
- 4,020
- 2,103
- Capital Work in Progress
- 43
- 0
- 682
- 806
- Cash & Bank
- 157
- 228
- Total Assets
- 4,020
- Total Debt
- 608
- Net Working Capital
- 768
- Contingent Liabilities
- 15
- Book Value per Share
- 89.96
- Face Value
- 2.00
- Total Debt
- 608
- Net Working Capital
- 768
- Contingent Liabilities
- 15
- Book Value per Share
- 89.96
- Face Value
- 2.00
Mar 2026
- Equity Capital
- 87
- 2,618
- 122
- Trade Payables
- 597
- 1,121
- Total Liabilities
- 4,545
- 2,103
- Capital Work in Progress
- 69
- 0
- 803
- 1,045
- Cash & Bank
- 270
- 255
- Total Assets
- 4,545
- Total Debt
- 436
- Net Working Capital
- 1,309
- Contingent Liabilities
- 27
- Book Value per Share
- 61.92
- Face Value
- 2.00
- Total Debt
- 436
- Net Working Capital
- 1,309
- Contingent Liabilities
- 27
- Book Value per Share
- 61.92
- Face Value
- 2.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| -7 | 45 | 116 | 115 | 115 | 31 | 17 | 31 | 345 | 323 | |
| Cash from Investing | -116 | 7 | -68 | -72 | 10 | -96 | -65 | -6 | -447 | -84 |
| Cash from Financing | 147 | -57 | -20 | -43 | -139 | 67 | 32 | -1 | 87 | -123 |
| 24 | -5 | 28 | 0 | -14 | 2 | -16 | 23 | -15 | 115 | |
| Free Cash Flow | -133 | 45 | 56 | -3 | 106 | -21 | -141 | 31 | -2,005 | 52 |
| OCF / Net Profit | 0.52 | 4.44 | 2.04 | 1.41 | 1.10 | 0.68 | -0.14 | -1.03 | 21.87 | 1.44 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 72 | 183 | -3 | -28 | -2,030 | -2,084 |
| OCF / Net Profit | 0.52 | 4.44 | 2.04 | 1.41 | 1.10 | 0.68 | -0.14 | -1.03 | 21.87 | 1.44 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 72 | 183 | -3 | -28 | -2,030 | -2,084 |
Mar 2017
- -7
- Cash from Investing
- -116
- Cash from Financing
- 147
- 24
- Free Cash Flow
- -133
- OCF / Net Profit
- 0.52
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.52
- Cumulative 5-Year FCF
- 0
Mar 2018
- 45
- Cash from Investing
- 7
- Cash from Financing
- -57
- -5
- Free Cash Flow
- 45
- OCF / Net Profit
- 4.44
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 4.44
- Cumulative 5-Year FCF
- 0
Mar 2019
- 116
- Cash from Investing
- -68
- Cash from Financing
- -20
- 28
- Free Cash Flow
- 56
- OCF / Net Profit
- 2.04
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.04
- Cumulative 5-Year FCF
- 0
Mar 2020
- 115
- Cash from Investing
- -72
- Cash from Financing
- -43
- 0
- Free Cash Flow
- -3
- OCF / Net Profit
- 1.41
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.41
- Cumulative 5-Year FCF
- 0
Mar 2021
- 115
- Cash from Investing
- 10
- Cash from Financing
- -139
- -14
- Free Cash Flow
- 106
- OCF / Net Profit
- 1.10
- Cumulative 5-Year FCF
- 72
- OCF / Net Profit
- 1.10
- Cumulative 5-Year FCF
- 72
Mar 2022
- 31
- Cash from Investing
- -96
- Cash from Financing
- 67
- 2
- Free Cash Flow
- -21
- OCF / Net Profit
- 0.68
- Cumulative 5-Year FCF
- 183
- OCF / Net Profit
- 0.68
- Cumulative 5-Year FCF
- 183
Mar 2023
- 17
- Cash from Investing
- -65
- Cash from Financing
- 32
- -16
- Free Cash Flow
- -141
- OCF / Net Profit
- -0.14
- Cumulative 5-Year FCF
- -3
- OCF / Net Profit
- -0.14
- Cumulative 5-Year FCF
- -3
Mar 2024
- 31
- Cash from Investing
- -6
- Cash from Financing
- -1
- 23
- Free Cash Flow
- 31
- OCF / Net Profit
- -1.03
- Cumulative 5-Year FCF
- -28
- OCF / Net Profit
- -1.03
- Cumulative 5-Year FCF
- -28
Mar 2025
- 345
- Cash from Investing
- -447
- Cash from Financing
- 87
- -15
- Free Cash Flow
- -2,005
- OCF / Net Profit
- 21.87
- Cumulative 5-Year FCF
- -2,030
- OCF / Net Profit
- 21.87
- Cumulative 5-Year FCF
- -2,030
Mar 2026
- 323
- Cash from Investing
- -84
- Cash from Financing
- -123
- 115
- Free Cash Flow
- 52
- OCF / Net Profit
- 1.44
- Cumulative 5-Year FCF
- -2,084
- OCF / Net Profit
- 1.44
- Cumulative 5-Year FCF
- -2,084
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | -0.57 | 17.30 | 1.97 | 2.81 | 3.84 | 1.65 | -4.86 | -1.44 | 0.93 | 4.06 |
| Book Value (₹) | 39.44 | 25.85 | 27.86 | 27.10 | 28.98 | 25.97 | 25.76 | 23.22 | 89.96 | 61.92 |
| Dividend per Share (₹) | 0.00 | 0.20 | 0.20 | 0.00 | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 1.08 | 2.11 | 4.00 | 5.34 | 6.24 | 3.88 | -2.66 | 1.28 | 10.17 | 10.49 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 7.84% | 11.72% | 12.62% | 14.98% | 15.88% | 8.34% | 1.26% | 4.35% | 12.77% | 19.08% |
| Net Margin % | -2.01% | 1.20% | 5.37% | 6.81% | 7.53% | 3.10% | -8.39% | -2.10% | 0.52% | 6.57% |
| ROE % | -1.47% | 1.28% | 8.63% | 12.06% | 15.00% | 6.56% | -18.95% | -4.85% | 1.11% | 9.06% |
| ROCE % | 1.05% | 4.84% | 9.24% | 12.59% | 16.24% | 7.01% | -9.71% | -0.60% | 4.80% | 13.10% |
| -0.81% | 0.63% | 4.14% | 5.73% | 7.19% | 3.06% | -8.21% | -1.96% | 0.57% | 5.25% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 118 | 110 | 93 | 90 | 87 | 85 | 84 | 88 | 69 | 99 |
| Inventory Days | 78 | 69 | 62 | 64 | 64 | 78 | 87 | 90 | 62 | 79 |
| Payable Days | 178 | 144 | 124 | 130 | 118 | 112 | 110 | 119 | 92 | 127 |
| 19 | 35 | 30 | 24 | 34 | 51 | 61 | 58 | 40 | 51 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.43x | 0.48x | 0.47x | 0.51x | 0.31x | 0.49x | 0.62x | 0.78x | 0.27x | 0.16x |
| Interest Coverage (x) | 0.49x | 1.72x | 2.80x | 3.63x | 6.60x | 4.36x | -2.88x | -0.14x | 1.15x | 6.04x |
| 1.09x | 1.25x | 1.38x | 1.41x | 1.49x | 1.50x | 1.40x | 1.28x | 1.76x | 2.38x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 12.76% | 24.03% | 22.58% | 13.46% | 15.47% | 3.76% | 0.57% | -3.60% | 119.52% | 13.75% |
| Operating Profit Growth % | -21.10% | 84.30% | 34.20% | 35.03% | 22.18% | -45.45% | -84.74% | 294.50% | 480.10% | 65.80% |
| Net Profit Growth % | 22.83% | 173.49% | 458.27% | 44.25% | 27.31% | -57.14% | -372.49% | 75.72% | 153.24% | 1324.82% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 70.40% | 164.50% | 337.51% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 141.01x | 45.14x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 4.96x | 1.45x | 2.96x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 45.01x | 8.87x | 11.74x |
Mar 2017
- EPS (₹)
- -0.57
- Book Value (₹)
- 39.44
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.08
- Operating Margin %
- 7.84%
- Net Margin %
- -2.01%
- ROE %
- -1.47%
- ROCE %
- 1.05%
- -0.81%
- Debtor Days
- 118
- Inventory Days
- 78
- Payable Days
- 178
- 19
- Debt to Equity (x)
- 0.43x
- Interest Coverage (x)
- 0.49x
- 1.09x
- Revenue Growth %
- 12.76%
- Operating Profit Growth %
- -21.10%
- Net Profit Growth %
- 22.83%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 17.30
- Book Value (₹)
- 25.85
- Dividend per Share (₹)
- 0.20
- Cash EPS (₹)
- 2.11
- Operating Margin %
- 11.72%
- Net Margin %
- 1.20%
- ROE %
- 1.28%
- ROCE %
- 4.84%
- 0.63%
- Debtor Days
- 110
- Inventory Days
- 69
- Payable Days
- 144
- 35
- Debt to Equity (x)
- 0.48x
- Interest Coverage (x)
- 1.72x
- 1.25x
- Revenue Growth %
- 24.03%
- Operating Profit Growth %
- 84.30%
- Net Profit Growth %
- 173.49%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 1.97
- Book Value (₹)
- 27.86
- Dividend per Share (₹)
- 0.20
- Cash EPS (₹)
- 4.00
- Operating Margin %
- 12.62%
- Net Margin %
- 5.37%
- ROE %
- 8.63%
- ROCE %
- 9.24%
- 4.14%
- Debtor Days
- 93
- Inventory Days
- 62
- Payable Days
- 124
- 30
- Debt to Equity (x)
- 0.47x
- Interest Coverage (x)
- 2.80x
- 1.38x
- Revenue Growth %
- 22.58%
- Operating Profit Growth %
- 34.20%
- Net Profit Growth %
- 458.27%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 2.81
- Book Value (₹)
- 27.10
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.34
- Operating Margin %
- 14.98%
- Net Margin %
- 6.81%
- ROE %
- 12.06%
- ROCE %
- 12.59%
- 5.73%
- Debtor Days
- 90
- Inventory Days
- 64
- Payable Days
- 130
- 24
- Debt to Equity (x)
- 0.51x
- Interest Coverage (x)
- 3.63x
- 1.41x
- Revenue Growth %
- 13.46%
- Operating Profit Growth %
- 35.03%
- Net Profit Growth %
- 44.25%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 3.84
- Book Value (₹)
- 28.98
- Dividend per Share (₹)
- 0.50
- Cash EPS (₹)
- 6.24
- Operating Margin %
- 15.88%
- Net Margin %
- 7.53%
- ROE %
- 15.00%
- ROCE %
- 16.24%
- 7.19%
- Debtor Days
- 87
- Inventory Days
- 64
- Payable Days
- 118
- 34
- Debt to Equity (x)
- 0.31x
- Interest Coverage (x)
- 6.60x
- 1.49x
- Revenue Growth %
- 15.47%
- Operating Profit Growth %
- 22.18%
- Net Profit Growth %
- 27.31%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 1.65
- Book Value (₹)
- 25.97
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 3.88
- Operating Margin %
- 8.34%
- Net Margin %
- 3.10%
- ROE %
- 6.56%
- ROCE %
- 7.01%
- 3.06%
- Debtor Days
- 85
- Inventory Days
- 78
- Payable Days
- 112
- 51
- Debt to Equity (x)
- 0.49x
- Interest Coverage (x)
- 4.36x
- 1.50x
- Revenue Growth %
- 3.76%
- Operating Profit Growth %
- -45.45%
- Net Profit Growth %
- -57.14%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- -4.86
- Book Value (₹)
- 25.76
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -2.66
- Operating Margin %
- 1.26%
- Net Margin %
- -8.39%
- ROE %
- -18.95%
- ROCE %
- -9.71%
- -8.21%
- Debtor Days
- 84
- Inventory Days
- 87
- Payable Days
- 110
- 61
- Debt to Equity (x)
- 0.62x
- Interest Coverage (x)
- -2.88x
- 1.40x
- Revenue Growth %
- 0.57%
- Operating Profit Growth %
- -84.74%
- Net Profit Growth %
- -372.49%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- -1.44
- Book Value (₹)
- 23.22
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.28
- Operating Margin %
- 4.35%
- Net Margin %
- -2.10%
- ROE %
- -4.85%
- ROCE %
- -0.60%
- -1.96%
- Debtor Days
- 88
- Inventory Days
- 90
- Payable Days
- 119
- 58
- Debt to Equity (x)
- 0.78x
- Interest Coverage (x)
- -0.14x
- 1.28x
- Revenue Growth %
- -3.60%
- Operating Profit Growth %
- 294.50%
- Net Profit Growth %
- 75.72%
- 70.40%
- P/E (x)
- 0.00x
- P/B (x)
- 4.96x
- Dividend Yield %
- 0.00%
- 45.01x
Mar 2025
- EPS (₹)
- 0.93
- Book Value (₹)
- 89.96
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 10.17
- Operating Margin %
- 12.77%
- Net Margin %
- 0.52%
- ROE %
- 1.11%
- ROCE %
- 4.80%
- 0.57%
- Debtor Days
- 69
- Inventory Days
- 62
- Payable Days
- 92
- 40
- Debt to Equity (x)
- 0.27x
- Interest Coverage (x)
- 1.15x
- 1.76x
- Revenue Growth %
- 119.52%
- Operating Profit Growth %
- 480.10%
- Net Profit Growth %
- 153.24%
- 164.50%
- P/E (x)
- 141.01x
- P/B (x)
- 1.45x
- Dividend Yield %
- 0.00%
- 8.87x
Mar 2026
- EPS (₹)
- 4.06
- Book Value (₹)
- 61.92
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 10.49
- Operating Margin %
- 19.08%
- Net Margin %
- 6.57%
- ROE %
- 9.06%
- ROCE %
- 13.10%
- 5.25%
- Debtor Days
- 99
- Inventory Days
- 79
- Payable Days
- 127
- 51
- Debt to Equity (x)
- 0.16x
- Interest Coverage (x)
- 6.04x
- 2.38x
- Revenue Growth %
- 13.75%
- Operating Profit Growth %
- 65.80%
- Net Profit Growth %
- 1324.82%
- 337.51%
- P/E (x)
- 45.14x
- P/B (x)
- 2.96x
- Dividend Yield %
- 0.00%
- 11.74x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-16 - Viyash Scientific Limited has informed the Exchange about Transcript
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-12 - Viyash Scientific Limited has informed the Exchange about Link of Earning call Recording
Annual Reports
Credit Ratings
- Credit Rating- Others
2026-05-22 - Viyash Scientific Limited has informed the Exchange about Credit Rating- India Ratings and Research (Ind-Ra), at the Company s request, has withdrawn the ratingassigned to the Company s bank loan facilities
Concalls
Aug 2026
Jun 2026
May 2026